Seropositivity for Chlamydia Pneumoniae and Mycoplasma Pneumoniae in Asthmatic Children

Basit Öğe Kaydı
dc.contributor.authorTutanc, Murat
dc.contributor.authorGurkan, M. Fuat
dc.contributor.authorYel, Servet
dc.contributor.authorGunes, Ali
dc.contributor.authorKonca, Capan
dc.contributor.authorBilen, Gulseren
dc.date.accessioned2024-04-24T17:24:40Z
dc.date.available2024-04-24T17:24:40Z
dc.date.issued2015
dc.departmentDicle Üniversitesien_US
dc.description.abstractAcute respiratory tract infections may trigger acute asthma attacks and may be held responsible for etiopathogenesis in children with asthma. Although bacterial infections attract a limited amount of attention, recently Chlamydia pneumoniae (CP) and Mycoplasma pneumoniae (MP), in particular, are reported to be the possible factors. IgM and IgG seroprevalence was investigated in 66 children patients with bronchial asthma (between the ages of 3 and 14) for CP and Mycoplasma pneumoniae. In a total of 66 cases, 18 (27.2%) patients were detected with IgG positivity for CP whereas 27 of them (40.9%) were detected with IgG positivity for MP. IgG positivity was determined in 6 patients (13.0%) in the control group for CP, and in 6 patients (10.8%) in the control group for MP. The rate of the asthma patients with IgG seropositivity for MP was 4 times higher than that of the control group. It was seen that IgG antibody seropositivity for CP was higher in those with more frequent attacks. No such difference was observed in terms of IgG antibody seropositivity for M. pneumoniae. There are many studies indicating that CP and MP infections take an importance place in the etiology of bronchial asthma and asthma attacks in children. The results obtained reveal the effect of both microorganisms on the etiopathogenesis of the bronchial asthma and the increased number of asthma attacks.en_US
dc.identifier.doi10.4328/JCAM.2052
dc.identifier.endpage357en_US
dc.identifier.issn1309-0720
dc.identifier.issn1309-2014
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-84928551185
dc.identifier.scopusqualityN/A
dc.identifier.startpage353en_US
dc.identifier.trdizinid170352
dc.identifier.urihttps://doi.org/10.4328/JCAM.2052
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/170352
dc.identifier.urihttps://hdl.handle.net/11468/19780
dc.identifier.volume6en_US
dc.identifier.wosWOS:000376564000035
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoenen_US
dc.publisherDerman Medical Publen_US
dc.relation.ispartofJournal of Clinical and Analytical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBronchial Asthmaen_US
dc.subjectChlamydia Pneumoniaeen_US
dc.subjectMycoplasma Pneumoniaen_US
dc.subjectChildrenen_US
dc.titleSeropositivity for Chlamydia Pneumoniae and Mycoplasma Pneumoniae in Asthmatic Childrenen_US
dc.titleSeropositivity for Chlamydia Pneumoniae and Mycoplasma Pneumoniae in Asthmatic Children
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu